India rejects Pfizer's patent application for arthritis drug

India's patent office has again rejected US drug major Pfizer's new patent application for its rheumatoid arthritis medicine, tofacitinib, citing it did not enhance the efficacy of the existing approved drug.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news